Merger Madness

In this chapter, Ben and David discuss the dual merger of Novo Nordisk and the incredible growth of the insulin market during the 1980s. They explore how the two companies drove each other to innovate and the significant increase in market size. The episode also touches on the remaining businesses within Novo and the challenges they face in the consolidated pharma market.